Blog

Oct 1, 2021

Merck’s experimental pill to treat covid-19 cuts risk of hospitalization and death in half, the pharmaceutical company reports

Posted by in category: biotech/medical

The drug, molnupiravir, could be the first oral antiviral medication for covid-19.

Comments are closed.